Promotion Expert Witnesses

California

Marketing, Pharmaceutical Regulation - Bio-similar drugs, Biotech & Pharma Marketing, Operations, Promotion, CNS Products, Medicare, Launch delay, Pharma Commercialization, Pharmaceutical Contracting & Pricing, Pharmaceutical Launch, Pharma Marketing, Pharma Sales, Specialty Pharma, DTC, Commercially Reasonable Efforts, CRE, Pharmaceuticals , Promotional compliance

Mr. Hosier is a strategic advisor to the life sciences industry drawing on 30 years of sales, marketing and managed markets experience in commercial healthcare organizations. He has provided insights to small molecule & biotechnology companies across multiple therapeutic areas but has maintained a heavy concentration in oncology and specialty pharmaceuticals. He has led brand launch; corporate, franchise, and strategic brand planning; commercial integration; organizational design; and operational effectiveness from multiple perspectives (as the client, as the independent consultant, and as an agency lead). Mr. Hosier’s firm has architected the launch of rare disease and oncology business units for multiple pharmaceutical clients (large and small); led development of the managed markets, trade, and distribution strategy for the launch of new chemical entities (NCEs) and 505(b)2 assets for various organizations; advised on commercially reasonable effort (CRE); and provided commerci...

Los Angeles, California

Marketing, Advertising - Marketing, Sales, Advertising, Ads, Promotion, Misleading Advertising, Deceptive Ads, Unfair Advertising, Business Practices, Intellectual Property, Patents, Deceptive Promotion, Trade dress, Unfair Competition, Breach of contract, Partners, Copyrights, Forensic Marketing, Social media, Distribution

Senior Marketing & Advertising Professional. Marketing Analyst. Marketing & Business Problem Solver in Objectives, Strategies and Tactics. Battle-tested, deposition-tested. 22+ years as Marketing and Advertising expert. Cases: Marketing; Advertising; Ads; breach of contract; business strategies, practices; business and professions code compliance and violations; unfair competition, contracts, sponsorships; deceptive, false advertising; media; intellectual property; patents; usage of models; advertising agencies; trade secrets; partner business practices; unfair advertising; deceptive advertising; violations of Lanham Act; unjust enrichment; trademarks at issue; comparative advertising/promotion; licensing; packaging; the value of advertising and media campaigns. I have been deposed, testified in court and arbitration: 57 times. Cases have included contracts between partners, directors, advertising agencies, clients, advertisers, suppliers, distributors, production firms an...

West New York, New Jersey

Marketing, Pharmaceutical Regulation - Bio-similar drugs, Biotech & Pharma Marketing, Operations, Promotion, CNS Products, Medicare, Launch delay, Pharma Commercialization, Pharmaceutical Contracting & Pricing, Pharmaceutical Launch, Pharma Marketing, Pharma Sales, Specialty Pharma, DTC, Commercially Reasonable Efforts, CRE, Pharmaceuticals , Promotional compliance

Mr. Hosier is a strategic advisor to the life sciences industry drawing on 30 years of sales, marketing and managed markets experience in commercial healthcare organizations. He has provided insights to small molecule & biotechnology companies across multiple therapeutic areas but has maintained a heavy concentration in oncology and specialty pharmaceuticals. He has led brand launch; corporate, franchise, and strategic brand planning; commercial integration; organizational design; and operational effectiveness from multiple perspectives (as the client, as the independent consultant, and as an agency lead). Mr. Hosier’s firm has architected the launch of rare disease and oncology business units for multiple pharmaceutical clients (large and small); led development of the managed markets, trade, and distribution strategy for the launch of new chemical entities (NCEs) and 505(b)2 assets for various organizations; advised on commercially reasonable effort (CRE); and provided commerci...

New York

Marketing, Pharmaceutical Regulation - Bio-similar drugs, Biotech & Pharma Marketing, Operations, Promotion, CNS Products, Medicare, Launch delay, Pharma Commercialization, Pharmaceutical Contracting & Pricing, Pharmaceutical Launch, Pharma Marketing, Pharma Sales, Specialty Pharma, DTC, Commercially Reasonable Efforts, CRE, Pharmaceuticals , Promotional compliance

Mr. Hosier is a strategic advisor to the life sciences industry drawing on 30 years of sales, marketing and managed markets experience in commercial healthcare organizations. He has provided insights to small molecule & biotechnology companies across multiple therapeutic areas but has maintained a heavy concentration in oncology and specialty pharmaceuticals. He has led brand launch; corporate, franchise, and strategic brand planning; commercial integration; organizational design; and operational effectiveness from multiple perspectives (as the client, as the independent consultant, and as an agency lead). Mr. Hosier’s firm has architected the launch of rare disease and oncology business units for multiple pharmaceutical clients (large and small); led development of the managed markets, trade, and distribution strategy for the launch of new chemical entities (NCEs) and 505(b)2 assets for various organizations; advised on commercially reasonable effort (CRE); and provided commerci...

Columbus, Ohio

Employment, Law Enf & Criminal Justice - employment law, termination, law enforcement, jury selection, police procedures, criminal justice, bias, decision making, algorithmic bias, generative ai, discrimination, implicit bias, unconscious bias, remote work, recruitment, use of force, promotion, racism, sexism, public procurement

Dr. Gleb Tsipursky is a world-renowned expert in bias and discrimination, focusing on employment law, fair housing, criminal justice, police procedures and use of force, law enforcement, and jury selection. He serves as the CEO of the boutique legal consultancy Disaster Avoidance Experts. His globally-renowned expertise has been featured in over 650 articles and more than 550 interviews in prominent venues, including Harvard Business Review, USA Today, Fortune, Fast Company, CBS News, Time, Scientific American, Psychology Today, Business Insider, Inc. Magazine, NPR, and The New York Times. He is the author of global best-sellers, "Never Go With Your Gut: How Pioneering Leaders Make the Best Decisions and Avoid Business Disasters" and "The Blindspots Between Us: How to Overcome Unconscious Cognitive Bias and Build Better Relationships." His writings have been translated into Chinese, Korean, German, Russian, Polish, and other languages. Dr. Tsipursky's expertise stems from 25 year...

Pennsylvania

Marketing, Pharmaceutical Regulation - Bio-similar drugs, Biotech & Pharma Marketing, Operations, Promotion, CNS Products, Medicare, Launch delay, Pharma Commercialization, Pharmaceutical Contracting & Pricing, Pharmaceutical Launch, Pharma Marketing, Pharma Sales, Specialty Pharma, DTC, Commercially Reasonable Efforts, CRE, Pharmaceuticals , Promotional compliance

Mr. Hosier is a strategic advisor to the life sciences industry drawing on 30 years of sales, marketing and managed markets experience in commercial healthcare organizations. He has provided insights to small molecule & biotechnology companies across multiple therapeutic areas but has maintained a heavy concentration in oncology and specialty pharmaceuticals. He has led brand launch; corporate, franchise, and strategic brand planning; commercial integration; organizational design; and operational effectiveness from multiple perspectives (as the client, as the independent consultant, and as an agency lead). Mr. Hosier’s firm has architected the launch of rare disease and oncology business units for multiple pharmaceutical clients (large and small); led development of the managed markets, trade, and distribution strategy for the launch of new chemical entities (NCEs) and 505(b)2 assets for various organizations; advised on commercially reasonable effort (CRE); and provided commerci...